申请人:BioCryst Pharmaceuticals, Inc.
公开号:EP2535345A1
公开(公告)日:2012-12-19
The invention provides compounds of Formula (I), as described herein, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates that are useful for preparing the compounds. The compounds of Formula (I) are useful as anti-viral agents and/or as anti-cancer agents.
本发明提供了本文所述的式(I)化合物,以及包含该化合物的药物组合物,以及用于制备该化合物的合成方法和中间体。式(I)化合物可用作抗病毒剂和/或抗癌剂。